Genprex, Inc. Capital Expenditures
Genprex, Inc. (GNPX) reported Capital Expenditures of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2023-03-31
- Genprex, Inc. payments to acquire property, plant, and equipment for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- Genprex, Inc. payments to acquire property, plant, and equipment for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- Genprex, Inc. payments to acquire property, plant, and equipment for the quarter ending 2022-06-30 was $0.00.
- Genprex, Inc. payments to acquire property, plant, and equipment for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- Genprex, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Genprex, Inc. payments to acquire property, plant, and equipment for fiscal 2021 was $31.70K, a 80.48% increase from fiscal 2020.
- Genprex, Inc. payments to acquire property, plant, and equipment for fiscal 2020 was $17.56K, a 47.37% decline from fiscal 2019.
- Genprex, Inc. payments to acquire property, plant, and equipment for fiscal 2019 was $33.37K, a 48.74% increase from fiscal 2018.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $0.00 derived: sum of 3 quarters · filed 2023-03-31 | $0.00 10-K · filed 2023-03-31 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | $11.22K derived: sum of 4 quarters · filed 2023-03-31 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 | $11.22K derived: sum of 3 quarters · filed 2023-03-31 | $22.56K derived: sum of 4 quarters · filed 2023-03-31 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-13 | $11.22K derived: sum of 2 quarters · filed 2023-03-31 | $22.56K derived: sum of 3 quarters · filed 2023-03-31 | -$60.00K derived: sum of 4 quarters · filed 2023-03-31 | |
| 2021-12-31 | $11.22K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $22.56K derived: sum of 2 quarters · filed 2023-03-31 | -$60.00K derived: sum of 3 quarters · filed 2023-03-31 | $31.70K 10-K · filed 2023-03-31 | $31.70K 10-K · filed 2022-03-30 |
| 2021-09-30 | $11.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$71.22K derived: sum of 2 quarters · filed 2022-11-14 | $20.48K 10-Q · filed 2022-11-14 | $23.52K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | -$82.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $9.14K 10-Q · filed 2022-08-12 | $12.18K derived: sum of 3 quarters · filed 2022-08-12 | $13.94K derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | $91.70K 10-Q · filed 2022-05-13 | $94.74K derived: sum of 2 quarters · filed 2022-05-13 | $96.50K derived: sum of 3 quarters · filed 2022-05-13 | $97.85K derived: sum of 4 quarters · filed 2022-05-13 | |
| 2020-12-31 | $3.04K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $4.80K derived: sum of 2 quarters · filed 2022-03-30 | $6.15K derived: sum of 3 quarters · filed 2022-03-30 | $17.56K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $1.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $3.12K derived: sum of 2 quarters · filed 2021-11-15 | $14.53K 10-Q · filed 2021-11-15 | $39.02K derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | $1.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $12.76K 10-Q · filed 2021-08-13 | $37.25K derived: sum of 3 quarters · filed 2021-08-13 | $40.07K derived: sum of 4 quarters · filed 2021-08-13 | |
| 2020-03-31 | $11.41K 10-Q · filed 2021-05-17 | $35.90K derived: sum of 2 quarters · filed 2021-05-17 | $38.72K derived: sum of 3 quarters · filed 2021-05-17 | $40.67K derived: sum of 4 quarters · filed 2021-05-17 | |
| 2019-12-31 | $24.49K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | $27.31K derived: sum of 2 quarters · filed 2021-03-26 | $29.26K derived: sum of 3 quarters · filed 2021-03-26 | $33.37K 10-K · filed 2021-03-26 | |
| 2019-09-30 | $2.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $4.77K derived: sum of 2 quarters · filed 2020-11-12 | $8.88K 10-Q · filed 2020-11-12 | $19.30K derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | $1.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $6.06K 10-Q · filed 2020-08-11 | $16.48K derived: sum of 3 quarters · filed 2020-08-11 | $19.97K derived: sum of 4 quarters · filed 2020-08-11 | |
| 2019-03-31 | $4.11K 10-Q · filed 2020-05-14 | $14.53K derived: sum of 2 quarters · filed 2020-05-14 | $18.02K derived: sum of 3 quarters · filed 2020-05-14 | $25.08K derived: sum of 4 quarters · filed 2020-05-14 | |
| 2018-12-31 | $10.42K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $13.91K derived: sum of 2 quarters · filed 2020-03-30 | $20.97K derived: sum of 3 quarters · filed 2020-03-30 | $22.43K 10-K · filed 2020-03-30 | |
| 2018-09-30 | $3.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $10.55K derived: sum of 2 quarters · filed 2019-11-14 | $12.02K 10-Q · filed 2019-11-14 | $11.91K derived: sum of 4 quarters · filed 2019-11-14 | |
| 2018-06-30 | $7.05K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2019-08-13 | $8.52K 10-Q · filed 2019-08-13 | $8.41K derived: sum of 3 quarters · filed 2019-08-13 | $8.52K derived: sum of 4 quarters · filed 2019-08-13 | |
| 2018-03-31 | $1.47K 10-Q/A · filed 2019-05-20 | $1.36K derived: sum of 2 quarters · filed 2019-05-20 | $1.47K derived: sum of 3 quarters · filed 2019-05-20 | $4.61K derived: sum of 4 quarters · filed 2019-05-20 | |
| 2017-12-31 | -$109.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $0.00 derived: sum of 2 quarters · filed 2019-04-01 | $3.14K derived: sum of 3 quarters · filed 2019-04-01 | $5.89K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $109.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $3.25K derived: sum of 2 quarters · filed 2018-11-14 | $6.00K 10-Q · filed 2018-11-14 | $10.98K derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-06-30 | $3.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $5.89K 10-Q · filed 2018-08-14 | $10.87K derived: sum of 3 quarters · filed 2018-08-14 | ||
| 2017-03-31 | $2.75K 10-Q · filed 2018-05-15 | $7.73K derived: sum of 2 quarters · filed 2018-05-15 | |||
| 2016-12-31 | $4.98K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-17 | $4.98K 10-K · filed 2018-04-17 | |||
| 2016-09-30 | $0.00 10-Q · filed 2017-12-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |